Literature DB >> 2828691

B-cell lymphoproliferation and lymphomagenesis are associated with clonotypic intracellular terminal regions of the Epstein-Barr virus.

N A Brown1, C R Liu, Y F Wang, C R Garcia.   

Abstract

We analyzed 17 B-cell lineages cloned from two patients with infectious mononucleosis and found that different B-cell lineages exhibited notable variation in the length of the fused Epstein-Barr virus (EBV) terminal region on intracellular EBV episomes. EBV termini in different B-cell clones from the same person differed by as many as 15 to 20 reiterations of the ca. 500-base-pair terminal repeat sequence. In contrast, analysis of seven B-cell lineages cloned from a patient with a fatal, oligoclonal lymphoma revealed that three of the cell clones had the same-sized EBV terminal region. These three clones had previously been shown, by immunoglobulin gene analysis, to be metastatic daughter cells descended from a common progenitor. Similarity of the EBV terminal regions in the three daughter clones suggested that EBV infected the progenitor cell before proliferation and metastasis. Individual, EBV-infected cells from a single individual showed sufficient heterogeneity in their EBV termini to allow use of terminal fragment size as a clonal marker in studies addressing the contribution of EBV to the clonal pathogenesis of tumors with which this virus has been associated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828691      PMCID: PMC253655          DOI: 10.1128/JVI.62.3.962-969.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.

Authors:  T Lindahl; A Adams; G Bjursell; G W Bornkamm; C Kaschka-Dierich; U Jehn
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  DNA of Epstein-Barr virus. II. Comparison of the molecular weights of restriction endonuclease fragments of the DNA of Epstein-Barr virus strains and identification of end fragments of the B95-8 strain.

Authors:  S D Hayward; E Kieff
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

4.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

Review 6.  The biology and chemistry of Epstein-Barr virus.

Authors:  E Kieff; T Dambaugh; M Heller; W King; A Cheung; V van Santen; M Hummel; C Beisel; S Fennewald; K Hennessy; T Heineman
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

7.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation.

Authors:  N Raab-Traub; K Flynn
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

8.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

9.  Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.

Authors:  D T Purtilo; D DeFlorio; L M Hutt; J Bhawan; J P Yang; R Otto; W Edwards
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

10.  Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.

Authors:  N A Brown; G Miller
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

View more
  13 in total

1.  EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA.

Authors:  Nara Lee; Walter N Moss; Therese A Yario; Joan A Steitz
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

2.  Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines.

Authors:  H Sato; T Takimoto; S Tanaka; J Tanaka; N Raab-Traub
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia.

Authors:  K Gilligan; P Rajadurai; L Resnick; N Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A.

Authors:  Cary A Moody; Rona S Scott; Nazanin Amirghahari; Cherie-Ann Nathan; Lawrence S Young; Chris W Dawson; John W Sixbey
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA.

Authors:  K Kawa-Ha; S Ishihara; T Ninomiya; K Yumura-Yagi; J Hara; F Murayama; A Tawa; K Hirai
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

Authors:  J Locker; M Nalesnik
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

7.  Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeats.

Authors:  Allison M Repic; Mingxia Shi; Rona S Scott; John W Sixbey
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

8.  Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergence.

Authors:  Cary A Moody; Rona S Scott; Tao Su; John W Sixbey
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Epstein-Barr virus infection in carcinoma of the salivary gland.

Authors:  N Raab-Traub; P Rajadurai; K Flynn; A P Lanier
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.

Authors:  L Flamand; I Stefanescu; D V Ablashi; J Menezes
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.